R
RAFAEL HOLDINGS, INC.
NYSE: RFL (Rafael Holdings, Inc.)
最近更新时间: 2天之前, 4:25AM2.07
-0.13 (-5.91%)
前收盘价格 | 2.20 |
收盘价格 | 2.11 |
成交量 | 296,266 |
平均成交量 (3个月) | 191,864 |
市值 | 72,660,520 |
价格/销量 (P/S) | 70.49 |
股市价格/股市净资产 (P/B) | 0.900 |
52周波幅 | |
利润日期 | 12 Jun 2025 - 16 Jun 2025 |
营业利益率 (TTM) | -1,633.43% |
稀释每股收益 (EPS TTM) | -0.920 |
季度收入增长率 (YOY) | 7.70% |
总债务/股东权益 (D/E MRQ) | 0.82% |
流动比率 (MRQ) | 3.85 |
营业现金流 (OCF TTM) | -11.44 M |
杠杆自由现金流 (LFCF TTM) | -6.60 M |
资产报酬率 (ROA TTM) | -9.82% |
股东权益报酬率 (ROE TTM) | -26.78% |
市场趋势
短期 | 中期 | ||
行业 | Real Estate Services (US) | 看跌 | 混合的 |
Real Estate Services (全球的) | 看跌 | 混合的 | |
股票 | Rafael Holdings, Inc. | - | - |
AIStockmoo 评分
-1.1
分析师共识 | -2.0 |
内部交易活动 | NA |
价格波动 | -4.5 |
技术平均移动指标 | 0.0 |
技术振荡指标 | 2.0 |
平均 | -1.13 |
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd. |
|
部门 | Real Estate |
行业 | Real Estate Services |
投资方式 | Small Value |
内部持股比例 | 54.75% |
机构持股比例 | 9.38% |
所有权
姓名 | 日期 | 持有股份 |
---|---|---|
Epiq Capital Group, Llc | 31 Dec 2024 | 243,030 |
Ieq Capital, Llc | 31 Mar 2025 | 238,878 |
Founders Fund V Management, Llc | 31 Mar 2025 | 169,451 |
Founders Fund Vi Management, Llc | 31 Mar 2025 | 38,784 |
该时间范围内无数据。
5年平均股息收益率 | 0.00% |
除息日 | 公告日期 | 支付日期 | 详情 |
---|---|---|---|
19 May 2010 | 27 May 2010 | 28 May 2010 | 12.818541 现金 |
18 Dec 2009 | 17 Dec 2009 | 31 Dec 2009 | 0.020211 现金 |
19 Jun 2009 | 18 Jun 2009 | 30 Jun 2009 | 0.014519 现金 |
20 Mar 2009 | 19 Mar 2009 | 31 Mar 2009 | 0.024223 现金 |
19 Dec 2008 | 18 Dec 2008 | 31 Dec 2008 | 0.140558 现金 |
19 Sep 2008 | 18 Sep 2008 | 30 Sep 2008 | 0.163271 现金 |
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合